» Articles » PMID: 14984577

Calciphylaxis and Metastatic Calcification Associated with Nephrogenic Fibrosing Dermopathy

Overview
Journal J Cutan Pathol
Publisher Wiley
Specialty Dermatology
Date 2004 Feb 27
PMID 14984577
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Calciphylaxis and metastatic calcification are known complications of chronic renal failure. Recently, a sclerosing condition of the skin termed nephrogenic fibrosing dermopathy (NFD) has been described in patients with renal disease, many of whom have undergone hemodialysis and/or renal transplantation. To our knowledge, the simultaneous occurrence of both conditions in the same patient, in the same lesion, has not been previously reported.

Case Report: We report the clinical, microscopic, and immunohistochemical features of two patients with chronic renal failure whose lesional skin biopsies showed both subcutaneous calcification and NFD. We consider the possible mechanisms that might explain the coexistence of these two disorders.

Results: Both patients presented with erythematous, indurated skin over the lower extremities. Purpuric, reticulated patches, necrosis, or ulceration were not observed. Microscopic examination showed the characteristic changes of NFD involving dermis and subcutaneous septa. In addition, biopsies of both individuals showed subcutaneous calcification, one in a diffuse distribution and the other involving the walls of subcutaneous vessels, as seen in calciphylaxis. Calcification was not suspected clinically in either case.

Conclusions: Metastatic calcification or calciphylaxis and NFD can occur simultaneously in patients with chronic renal failure and may be found together in the same lesion. Because subcutaneous calcification may not be suspected clinically in these cases, and in view of the adverse outcomes frequently associated with calciphylaxis, we recommend deep incisional biopsy of patients presenting with the clinical features of NFD. Both the fibrosis and the calcification of chronic renal failure may be related to the activity of transforming growth factor-beta/Smad signaling cascades.

Citing Articles

Treatment of calcinosis cutis associated with autoimmune connective tissue diseases.

Lau C, Smith G Arch Dermatol Res. 2024; 316(7):390.

PMID: 38878086 DOI: 10.1007/s00403-024-03148-0.


Erythema nodosum masking nephrogenic systemic fibrosis as initial skin manifestation.

Fuah K, Lim C BMC Nephrol. 2017; 18(1):249.

PMID: 28738858 PMC: 5525362. DOI: 10.1186/s12882-017-0666-7.


Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.

Edwards B, Laumann A, Nardone B, Miller F, Restaino J, Raisch D Br J Radiol. 2014; 87(1042):20140307.

PMID: 25230161 PMC: 4170864. DOI: 10.1259/bjr.20140307.


Complications of nephrogenic systemic fibrosis following repeated exposure to gadolinium in a man with hypothyroidism: a case report.

Aggarwal A, Froehlich A, Essah P, Brinster N, High W, Downs R J Med Case Rep. 2011; 5:566.

PMID: 22152227 PMC: 3253728. DOI: 10.1186/1752-1947-5-566.


Nephrogenic systemic fibrosis: current concepts.

Basak P, Jesmajian S Indian J Dermatol. 2011; 56(1):59-64.

PMID: 21572795 PMC: 3088938. DOI: 10.4103/0019-5154.77555.